Next Article in Journal
Previous Article in Journal
Int. J. Mol. Sci. 2013, 14(8), 15878-15884; doi:10.3390/ijms140815878
Editorial

Transparency of Reporting in Molecular Diagnostics

Received: 3 July 2013; in revised form: 23 July 2013 / Accepted: 23 July 2013 / Published: 30 July 2013
(This article belongs to the Section Molecular Pathology)
View Full-Text   |   Download PDF [159 KB, uploaded 19 June 2014]
Note: In lieu of an abstract, this is an excerpt from the first page.

Excerpt: The major advances made over the past few years in molecular and cell biology are providing a progressively more detailed understanding of the molecular pathways that control normal processes and become dysregulated in disease [1]. This has resulted in the documentation of numerous genetic, epigenetic, transcriptomic, proteomic and metabolomic biomarkers that promise earlier disease detection, more accurate patient stratification and better prognosis [2–5]. Furthermore, molecular fingerprinting of diseases can be predictive of drug response and so assist with specific targeting of drugs against disease-associated molecules and function [6]. [...]
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Bustin, S. Transparency of Reporting in Molecular Diagnostics. Int. J. Mol. Sci. 2013, 14, 15878-15884.

AMA Style

Bustin S. Transparency of Reporting in Molecular Diagnostics. International Journal of Molecular Sciences. 2013; 14(8):15878-15884.

Chicago/Turabian Style

Bustin, Stephen. 2013. "Transparency of Reporting in Molecular Diagnostics." Int. J. Mol. Sci. 14, no. 8: 15878-15884.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert